BRIEF: Clarity Medical director confronted by bankruptcy petition

1406.HK

Ophthalmology hospital operator Clarity Medical Group Holding Ltd. (1406.HK) announced Wednesday its executive director, Dr. Tse Wai Yip, has recently been subject to a bankruptcy petition filed against him by another doctor in the High Court of The Hong Kong Special Administrative Region, with the hearing set to take place on Oct. 29.

Tse is the founder of Clarity Medical and is “responsible for overseeing overall business administration and coordination of” the company, according to its latest annual report.

The petition comes not long after the company announced a series of changes to its board on Sept. 9, with Jiang Bo appointed as executive director and CEO, while former CEO Hui Yung Chris was re-designated as Co-CEO. The company also announced the resignations of non-executive director Ng Roy and independent non-executive director Ma Wai Hung Vincent.

Clarity Medical’s shares rose 1.3% to HK$0.395 when trading began on Thursday, though they are down by nearly half from their high this year of HK$0.77 in March.

By A. Au

,
, , ,

Related Articles

RELATED ARTICLES

  1. BRIEF: Yonghe Medical’s loss narrows on improved efficiency
    2279.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

Recent Articles

Kelun-Biotech reported rising sales of its signature cancer drug

Precision cancer drugs show promise for Kelun-Biotech

The company reported rising sales of its signature cancer drug and could get national insurance coverage for other key products, potentially boosting full-year earnings Key Takeaways: Topline revenue actually fell…
6990.HK
Illustration of China's hydrogen battery industry

China plays defense on EV batteries, offense on hydrogen

China rolls out new rules restricting the export of cutting-edge technology for EV battery manufacturing. How will this affect Chinese battery makers setting up factories abroad? And hydrogen fuel cell maker Refire reports its revenue fell 10% in the first half of the year. What does this say about a Chinese sector that's getting huge government support, but has yet to find a mass audience?
3750.HK 2570.HK